These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 23526953)

  • 1. Properties and molecular determinants of the natural flavone acacetin for blocking hKv4.3 channels.
    Wu HJ; Sun HY; Wu W; Zhang YH; Qin GW; Li GR
    PLoS One; 2013; 8(3):e57864. PubMed ID: 23526953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acacetin causes a frequency- and use-dependent blockade of hKv1.5 channels by binding to the S6 domain.
    Wu HJ; Wu W; Sun HY; Qin GW; Wang HB; Wang P; Yalamanchili HK; Wang J; Tse HF; Lau CP; Vanhoutte PM; Li GR
    J Mol Cell Cardiol; 2011 Dec; 51(6):966-73. PubMed ID: 21906601
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allitridi inhibits multiple cardiac potassium channels expressed in HEK 293 cells.
    Xu XH; Sun HY; Zhang YH; Wu W; Chen KH; Liu Y; Deng CY; Yu XY; Jin MW; Li GR
    PLoS One; 2012; 7(12):e51550. PubMed ID: 23272117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of carvedilol and quinidine for inhibiting hKv4.3 channel stably expressed in HEK 293 cells.
    Zhang R; Jie LJ; Wu WY; Wang ZQ; Sun HY; Xiao GS; Wang Y; Li YG; Li GR
    Eur J Pharmacol; 2019 Jun; 853():74-83. PubMed ID: 30880181
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acacetin, a Potent Transient Outward Current Blocker, May Be a Novel Therapeutic for
    Ye D; Zhou W; Hamrick SK; Tester DJ; Kim CSJ; Barajas-Martinez H; Hu D; Giudicessi JR; Antzelevitch C; Ackerman MJ
    Circ Genom Precis Med; 2022 Oct; 15(5):e003238. PubMed ID: 35861988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blocking characteristics of hKv1.5 and hKv4.3/hKChIP2.2 after administration of the novel antiarrhythmic compound AZD7009.
    Persson F; Carlsson L; Duker G; Jacobson I
    J Cardiovasc Pharmacol; 2005 Jul; 46(1):7-17. PubMed ID: 15965349
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of the transient outward current (Ito) in rat cardiac myocytes and human Kv4.3 channels by mefloquine.
    Perez-Cortes EJ; Islas AA; Arevalo JP; Mancilla C; Monjaraz E; Salinas-Stefanon EM
    Toxicol Appl Pharmacol; 2015 Oct; 288(2):203-12. PubMed ID: 26216464
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulation of human cardiac transient outward potassium current by EGFR tyrosine kinase and Src-family kinases.
    Zhang YH; Wu W; Sun HY; Deng XL; Cheng LC; Li X; Tse HF; Lau CP; Li GR
    Cardiovasc Res; 2012 Mar; 93(3):424-33. PubMed ID: 22198508
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Natural Flavone Acacetin Blocks Small Conductance Ca
    Chen KH; Liu H; Sun HY; Jin MW; Xiao GS; Wang Y; Li GR
    Front Pharmacol; 2017; 8():716. PubMed ID: 29081746
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR; Wang HB; Qin GW; Jin MW; Tang Q; Sun HY; Du XL; Deng XL; Zhang XH; Chen JB; Chen L; Xu XH; Cheng LC; Chiu SW; Tse HF; Vanhoutte PM; Lau CP
    Circulation; 2008 May; 117(19):2449-57. PubMed ID: 18458165
    [TBL] [Abstract][Full Text] [Related]  

  • 11. hKChIP2 is a functional modifier of hKv4.3 potassium channels: cloning and expression of a short hKChIP2 splice variant.
    Decher N; Uyguner O; Scherer CR; Karaman B; Yüksel-Apak M; Busch AE; Steinmeyer K; Wollnik B
    Cardiovasc Res; 2001 Nov; 52(2):255-64. PubMed ID: 11684073
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acacetin blocks kv1.3 channels and inhibits human T cell activation.
    Zhao N; Dong Q; Fu XX; Du LL; Cheng X; Du YM; Liao YH
    Cell Physiol Biochem; 2014; 34(4):1359-72. PubMed ID: 25301362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Riluzole inhibits Kv4.2 channels acting on the closed and closed inactivated states.
    Pacheco-Rojas DO; Delgado-Ramírez M; Villatoro-Gómez K; Moreno-Galindo EG; Rodríguez-Menchaca AA; Sánchez-Chapula JA; Ferrer T
    Eur J Pharmacol; 2021 May; 899():174026. PubMed ID: 33722592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External Ba(2+) block of Kv4.2 channels is enhanced in the closed-inactivated state.
    Kehl SJ; Fedida D; Wang Z
    Am J Physiol Cell Physiol; 2013 Feb; 304(4):C370-81. PubMed ID: 23242186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. hKv4.3 channel characterization and regulation by calcium channel antagonists.
    Calmels TP; Faivre JF; Cheval B; Javré JL; Rouanet S; Bril A
    Biochem Biophys Res Commun; 2001 Feb; 281(2):452-60. PubMed ID: 11181069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intravenous anesthetic propofol inhibits multiple human cardiac potassium channels.
    Yang L; Liu H; Sun HY; Li GR
    Anesthesiology; 2015 Mar; 122(3):571-84. PubMed ID: 25321870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of Kv4.3 current by accessory subunits.
    Deschênes I; Tomaselli GF
    FEBS Lett; 2002 Sep; 528(1-3):183-8. PubMed ID: 12297301
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of haloperidol on Kv4.3 potassium channels.
    Lee HJ; Sung KW; Hahn SJ
    Eur J Pharmacol; 2014 Oct; 740():1-8. PubMed ID: 24998874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterisation of Kv4.3 in HEK293 cells: comparison with the rat ventricular transient outward potassium current.
    Faivre JF; Calmels TP; Rouanet S; Javré JL; Cheval B; Bril A
    Cardiovasc Res; 1999 Jan; 41(1):188-99. PubMed ID: 10325966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.
    Kojima A; Ito Y; Ding WG; Kitagawa H; Matsuura H
    Eur J Pharmacol; 2015 Oct; 764():622-632. PubMed ID: 26256861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.